Yubo International Biotech Limited
YBGJ
$0.01
$0.01120.41%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -247.90K | -272.60K | -261.40K | -276.80K | -105.40K |
| Total Depreciation and Amortization | 1.00K | 29.10K | 44.40K | 43.60K | 45.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -20.80K | 6.60K | -24.20K | -84.50K | -19.40K |
| Change in Net Operating Assets | 183.70K | 29.70K | 112.50K | -41.40K | 65.60K |
| Cash from Operations | -84.10K | -207.20K | -128.80K | -359.10K | -14.00K |
| Capital Expenditure | -- | -- | -- | -- | 6.20K |
| Sale of Property, Plant, and Equipment | -- | -- | -79.90K | 0.00 | 79.90K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -79.90K | 0.00 | 86.10K |
| Total Debt Issued | 77.20K | 214.50K | 375.60K | 0.00 | 196.10K |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 77.20K | 214.50K | 375.60K | 0.00 | 196.10K |
| Foreign Exchange rate Adjustments | 8.50K | -5.00K | -169.80K | 359.60K | -267.60K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | 0.00 |
| Net Change in Cash | 1.60K | 2.30K | -2.90K | 500.00 | 600.00 |